Ritholtz Wealth Management raised its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 137.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 6,151 shares of the financial services provider's stock after buying an additional 3,557 shares during the period. Ritholtz Wealth Management's holdings in MetLife were worth $504,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. MeadowBrook Investment Advisors LLC lifted its holdings in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 220 shares during the period. Carmichael Hill & Associates Inc. lifted its stake in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock valued at $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC boosted its holdings in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after buying an additional 277 shares in the last quarter. Peterson Financial Group Inc. acquired a new stake in MetLife during the third quarter valued at $30,000. Finally, Fortitude Family Office LLC increased its holdings in MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock valued at $34,000 after buying an additional 266 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company's stock.
MetLife Trading Up 0.1 %
Shares of MET stock traded up $0.08 during trading on Tuesday, hitting $86.86. 1,479,585 shares of the stock traded hands, compared to its average volume of 3,402,039. The firm has a market capitalization of $60.14 billion, a P/E ratio of 17.54, a price-to-earnings-growth ratio of 0.64 and a beta of 1.07. MetLife, Inc. has a 52-week low of $64.61 and a 52-week high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The firm's fifty day moving average price is $83.51 and its 200-day moving average price is $79.66.
MetLife Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.51%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife's dividend payout ratio (DPR) is presently 43.95%.
Wall Street Analyst Weigh In
MET has been the topic of a number of analyst reports. TD Cowen raised their target price on MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a research report on Wednesday, November 27th. Jefferies Financial Group boosted their price objective on MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a research report on Friday, September 27th. Barclays upped their target price on MetLife from $90.00 to $96.00 and gave the stock an "overweight" rating in a research note on Monday, January 6th. StockNews.com cut shares of MetLife from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Finally, Piper Sandler boosted their price objective on MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat, MetLife currently has an average rating of "Moderate Buy" and a consensus target price of $89.92.
Read Our Latest Stock Report on MET
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
